Growth Metrics

NeuroPace (NPCE) Revenue Growth (3y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.63%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 8.01%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 5.28%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 15.36%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 10.52%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.73%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 17.14%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 2.92%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 7.43%
10 NeuroPace 558.86 Mn 504.88 Mn 18.05 Mn 15.10%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 15.10%
Dec 31, 2025 27.63%
Sep 30, 2025 34.84%
Jun 30, 2025 32.11%
Mar 31, 2025 25.58%
Dec 31, 2024 24.98%
Sep 30, 2024 26.76%
Jun 30, 2024 15.09%
Mar 31, 2024 17.34%
Dec 31, 2023 18.77%
Sep 30, 2023 8.75%
Jun 30, 2023 29.29%
Mar 31, 2023 13.21%